PULMONX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.92 USD | -0.89% |
|
+1.71% | -30.04% |
| 01/05 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
| 01/05 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
Presenter SpeechTravis Steed (Analysts)Travis Steed, Medical Device Analyst at Bank of America...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a cloud-based quantitative CT analysis service that offers physicians with a report that is designed for its solution, which includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation and has been validated in multiple randomized controlled clinical trials.
Calendar
30/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
9
USD
Average target price
15.4
USD
Spread / Average Target
+71.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -30.04% | 349M | |
| +73.10% | 12.39B | |
| -19.92% | 7.89B | |
| +8.05% | 6.59B | |
| +12.49% | 5.43B | |
| +40.80% | 4.96B | |
| -17.45% | 4.72B | |
| -18.76% | 4.02B | |
| -28.94% | 2.66B | |
| +61.09% | 2.37B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Transcript : Pulmonx Corporation Presents at Bank of America 2022 Healthcare Conference, May-10-2022 12